HeidelbergerMKendallFEThe precipitin reaction between type III pneumococcus polysaccharide and homologous antibody. J Exp Med1935; 61: 563–91.
2.
HolborowEJJohnsonGDStandardisation in immunofluorescence. Ann NY Acad Sci1983; 420: 62–4.
3.
Hughes-JonesNCAntigens, antibodies, and antigen antibody reaction concerning the human red cell. In: SelgsonD, ed. Blood Banking. Section D: CRC Handbook Series in Clinical Laboratory Science. Cleveland: CRC Press, 1977: 493–7.
4.
SingerJMPlotzCMThe latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med1956; 21: 288–92.
5.
WilkinsTABrouwersGMareschalJCCambasioCLHigh sensitivity, homogeneous particle based immunoassay for thyrotropin. Clin Chem1988; 34: 1749–52.
6.
TatlorRNMeasurement of variation and significance in serologic tests. Ann NY Acad Sci1983; 420: 13–21.
7.
LeedmanPJHarrisonPJHarrisonLCImmunoblotting for the detection of TSH receptor autoantibodies. J Autoimmune1991; 4: 529–42.
8.
LudgateMPerretJParmentierMGerardCLibertFDumontJEUse of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies. Mol Cell Endocrinol1990; 73: R13–18.
9.
FilettiSFotiDCostanteGRapoportB. Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor antibodies. J Clin Endocrinol Metab1991; 72: 1096–101.
10.
VittiPRotellaCMValenteWACohenJAlojSMLaccettiPCharacterisation of the optimal stimulatory effects of Graves' monoclonal and serum immunoglobulin G on adenosine 3′. 5′-monophosphate production in FRTL5 thyroid cells: A potential clinical assay. J din Endocrinol Metab1983; 57: 782–91.
11.
NordykeRAGilbertFIMiyamotoLAFleuryKAThe superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med1993; 153: 862–5.
12.
HaubruckHMauchLCookNJSteffensUHuntNBertholdHExpression of recombinant thyroid peroxidase by the baculovirus system and its use in ELISA screening for diagnosis of autoimmune thyroid disease. Autoimmunity1993; 15: 275–84.
13.
WardA MilfordWhitePAEDangerfieldVJMFinchSGEvaluation of seven commercial kits for the detection of thyroglobulin and thyroid microsomal antibodies. DH Autoimmune Serology Kit Evaluation Unit July 1989; STD/89/30.
14.
BronsonRCooperGRosenfeldD. Sperm antibodies: Their role in infertility. Fertil Steril1984; 42: 171–83.
15.
TungK. Immunologic basis of male infertility [Editorial]. Lab Invest1987; 57: 1–4.
16.
MeinertzHHjortT. Detection of autoimmunity to sperm: Mixed antiglobulin reaction (MAR) test or sperm agglutination? A study on 537 men from infertile couples. Fertil Steril1986: 46: 86–91.
17.
LynchDMLealiBAHoweSEA comparison of sperm agglutination and immobilization assays with a quantitative ELISA for anti-sperm antibody in serum. Fertil Steril1986; 46: 285–92.
18.
SajiFNegoroTOhashiKTanizawaOKatoM. Clinical evaluation of the enzyme-linked immunosorbent assay (ELISA) kit for antisperm antibodies. Fertil Steril1988; 50: 644–7.
19.
VandelliCBottazzoGFFranceschiF. Autoantibodies to gastrin-producing cells in antral (type B) chronic gastritis. N Engl J Med1979; 300: 1406–10.
20.
CumminsDArdemanS. Intrinsic factor antibodies and pernicious anaemia. Lancet1991; 338: 383–4.
21.
GleesonPATonBHMolecular targets in pernicious anaemia. Immunol Today1991; 12: 233–8.
22.
HawkinsBRMcDonaldBLDawkinsRLCharacterization of immunofluorescent heterophile antibodies which may be confused with autoantibodies. J din Pathol1977; 30: 299–307.
23.
SamloffIMKleinmanMSTurnerMDSobelMVJeffries GH. Blocking and binding antibodies to intrinsic factor and parietal cell antibody in pernicious anaemia. Gastroenterology1968; 55: 575–83.
24.
GottliebCLauKSWassermanLRHerbertV. Rapid charcoal assay for intrinsic factor (IF), gastric juice unsaturated B12 binding capacity, antibody to IF, and serum unsaturated B12 binding capacity. Blood1965; 25: 875–83.
25.
CalabuigMTorregosaRPoloPTusetLTomasCAlvarezVSerological markers and celiac disease: A new diagnostic approach?J Pediatr Gastroenterol Nutr1990; 10: 435–42.
26.
UnsworthDJWalker-SmithJAHolborowEJGliadin and reticulin antibodies in childhood coeliac disease. Lancet1983; 1(8329): 874–5.
27.
MawhinneyHTomkinGHGluten enteropathy associated with selective IgA deficiency. Lancet1971; 716: 121–4.
28.
HakeemVFifieldRAl-BayatyHFAldredMJWalkerDMWilliamsJSalivary IgA antigliadin antibody as a marker for coeliac disease. Archiv Dis Child1992; 67: 724–7.
29.
LadinserBRossipalEPittschielerK. Endomysium antibodies in coeliac disease: An improved method. Gut1994; 35: 776–8.
30.
RizzettoMDoniachD. Types of ‘reticulin’ antibodies detected in human sera by immunofluorescence. J Clin Pathol1973; 26: 841–51.
KennyRPCzajaAJLudwigJDicksonERFrequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci1986; 31: 705–11.
33.
BergPAKleinR. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: Definition and clinical relevance [published erratum appears in Dig Dis 1992; 10: 248]Dig Dis1992; 10: 85–101.
34.
LidmanK. Clinical diagnosis in patients with smooth muscle antibodies. A study of a one-year material. Acta Med Scand1976; 200: 403–7.
35.
BrethertonLBrownCPedersonJSTohBHClarkeFMMackayIRELISA assay for IgG autoantibody to G-actin: Comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol1983; 51: 611–6.
36.
HombergJ-CAbuafNBernardOIslamSAlvarezFKhalilSHChronic active hepatitis associated with antiliver/kidney micro-some antibody type 1: A second type of “autoimmune” hepatitis. Hepatology1987; 7: 1333–9.
37.
HombergJ-CAndreCAbuafN. A new anti-liver-kidney microsomal antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol1984; 55: 561–70.
38.
PhilippTDurazzoMTrautweinCAlexBStraubPLambJGRecognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Comment in Lancet1994; 344: 560–1 & Lancet 1994; 344: 1369–70.
39.
MuratoriLLenziMMaYCataletaMMieli-VerganiGVerganiDHeterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Cut1995; 37: 406–12.
40.
BeutnerEHChorzelskiTPJablonskaS. Immunofluorescence tests: Clinical significance of sera and skin in bullous diseases. Int J Dermatol1985; 24: 405–21.
41.
StanleyJRPemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest1989; 83: 1443–8.
42.
AmagaiMKarpatiSPrussickRKlaus-KovtunVStanleyJRAutoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest1992; 90: 919–26.
43.
GiudiceGJEmeryDJZelicksonBDAnhaltGJLiuZDiazLABullous pemphigoid and herpes gestationis autoantibodies recognize a common noncollagenous site on the BP180 ectodomain. J Immunol1993; 151: 5742–50.
44.
Newsom-DavisJPinchingAJVincentAWilsonSGFunction of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange. Neurology1978; 28: 266–72.
45.
LindstromJMSeyboldMELennonVAWhittinghamSDuaneDDAntibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value. Neurology1976; 26: 1054–59.
46.
SomnierFEAntiacetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: The use of cell line TE671 as a source of AChR antigen. J Neuroimmunol1994; 51: 63–8.
47.
BonifacioECobainTJDawkinsRLGriffithsMKaldenJRPeterJBComparison and standardisation of measurement of anti-acetylcholine receptor antibody between laboratories. Autoimmunity1988; 1: 59–66.
48.
CarranoJASwansonNRDawkinsRLAn enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: Comparison with indirect immunofluorescence. J Immunol Meth1983; 59: 301–14.
49.
LiZForesterNVincentA. Modulation of acetylcholine receptor function in TE671 d(rhabdomyosarcoma) cells by non-AChR ligands: Possible relevance to seronegative myasthenia gravis. J Neuroimmunol1996; 64: 179–83.
50.
WellerMStevensASommerNDichgansJKapplerBWietholterH. Ganglioside antibodies: A lack of diagnostic specificity and clinical utility?J Neurol1992; 239: 455–9.
51.
SherEGottiCCanalNScoppettaCPiccoloGEvoliASpecificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet1989; ii: 640–3.
52.
WieslanderJBarrJFButkowskiRJEdwardsSJBygren P, Heinegard D, et al. Goodpasture antigen of the glomerular basement membrane: Localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA1984; 81: 3838–42.
53.
McPhaulJJDixonFJCharacterisation of human anti-glomerular basement membrane antibodies eluted from glomerulonephritic kidneys. J Clin Invest1970; 49: 308–17.
54.
SavageCOSWinearlsCGJonesSMarshallPDLockwoodCMProspective study of radioim-munoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet1987; i: 1389–93.
55.
EgnerWChapelHMTitration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol1990; 82: 244–9.
56.
Anonymous. Anti neutrophil cytoplasm antibodies. Proceedings of the 1st International Workshop on ANCA. Copenhagen, 1988. Apmis Suppl1989; 6: 1–49.
57.
LudemanJUtectBGrossWLAnti-ncutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med1990; 171: 357–62.
58.
FalkRJJennetteCJAnti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med1988; 318: 1651–7.
59.
OwinataAAPeterJBAgopianMRittenhouseJLiuYBarkaN. Use of flow cytometry for quantification of anti-neutrophil cytoplasmic antibodies. Sixth Annual Meeting of Clinical Application of Cytometry, South Carolina, September 1991.
60.
JayneDRWMarshallPDJonesSLLockwoodCMAutoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int1990; 37: 965–70.
61.
LockRJDetection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol1994; 47: 4–8.
62.
NatvigJBGaarderPITurnerMWIgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol1972; 12: 177–84.
63.
JonssonTValdimarssonH. Is measurement of rheumatoid factor isotypes clinically useful?Ann Rheum Dis1993; 52: 161–4.
64.
WaalerE. On the occurrence of a factor in human serum activating the specific agglutination of sheep corpuscles. Acta Pathol Microbiol Scand1940; 1: 172–88.
65.
RoseHMRaganCPearceELipmanMODifferential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med1949; 68: 1–6.
66.
FriouGJThe early days of the antinuclear antibody story: Where and how did it all start?Ann Med Interne (Paris)1993; 144: 154–6.
67.
HumbelRLKaduschP. Use of HEp-2 cells in the IF test for detection of antinuclear antibodies. Protides of the biological fluids. In: PeetersH, ed. Proceedings 35th Colloquium, Vol. 33. Oxford: Pergamon Press, 1985: 385–7.
68.
FeltkampTEWKleinFJanssensMBJAStandardisation of the quantitative determination of antinuclear antibodies (ANA) with a homogeneous pattern. Ann Rheum Dis1988; 47: 906–9.
69.
HollingsworthPNBonifacioEDawkinsRLUse of a standard curve improves precision and concordance of antinuclear antibody measurement. J Clin Lab Immunol1987; 22: 197–200.
70.
HomburgerHALaboratory medicine and pathology: Cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc1995; 70: 183–4.
71.
MoldenDPNakamuraRMTanEMStandardisation of the immunofluorescence test for autoantibody to nuclear antigens (ANA): Use of reference sera of defined antibody specificity. Am J Clin Pathol1984; 82: 57–66.
72.
SmeenkRJTMeasurement of antibodies to DNA. In: van VenrooijWJMainiRN, eds Manual of Biological Markers of DiseaseVol. A8. Netherlands: Kleuwer. 1993: 1–12.
73.
SwaakTSmeenkRJDetection of anti-dsDNA as a diagnosis tool: A prospective study in 441 nonsystemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis1985; 44: 245–51.
74.
BorgEJHorstGHummellEJLimburghPCKallenbergCGMeasurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation on systemic lupus erythematosus, a long-term, prospective study. Arth Rheum1990; 33: 634–43.
75.
BrinkmanKTermaatRMvan den BrinkHBerdenJSmeenkR. The specificity of the anti-dsDNA ELISA. A closer look. J Immunol Meth1991; 139: 91–100.
76.
BunnCKvederT. Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens. In: van VenrooijWJMainiRN, eds Manual of Biological Markers of DiseaseVol. A3. Netherlands: Kleuwer, 1993: 1–12.
77.
VerheijenRSaldenMvan VenrooijWJProtein Blotting. In: van VenrooijWJMainiRN, eds Manual of Biological Markers of Disease, Vol. A4. Netherlands: Kleuwer, 1993: 1–25.
78.
CharlesPJMainiRNEnzyme-linked immunosorbent assay in the rheumatological laboratory. In: van VenrooijWJMainiRN, eds Manual of Biological Markers of DiseaseVol. A.5. Netherlands: Kleuwer, 1993: 1–23.
79.
VenablesPJWCharlesPJBuchannanRCTungYiMumfordPAMainiRNQuantification and detection of isotypes of anti-SSB antibodies by ELISA and Farr assays using affinity purified antigens. Arth Rheum1982; 26: 146–55.
80.
MoroiYPeeblesCFritlerMJSteigerwaldJTanEMAutoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA1980; 77: 1627–31.
81.
WeinerESEarnshawWCSnecalJBodwellBJohnsonPRothfieldNFClinical associations of anticentromere antibodies and antibodies to topoisomerase 1. Arth Rheum1988; 31: 378–85.
82.
HuntJESimpsonRJKrilisSAIdentification of a region of B2-GP critical for lipid binding and anticardiolipin antibody cofactor. Proc Nat Acad Sci1993; 90: 2141–5.
83.
RoubeyRASImmunology of the antiphospholipid antibody syndrome. Arth Rheum1996; 39: 1444–54.
84.
ReberGArvieuxJCombyEDegenneDde MoerloosePSanmarcoMPotronGMulticenter evaluation of nine commercial kits for the quantification of anticardiolipin antibodies. Thromb Haem1995; 73: 444–52.
85.
WardAMWhitePAEMeasuring cardiolipin antibodies. Brit Med J1995; 310: 1472–3.